Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue

International Journal of Oncology

Volumn 42, Issue 1, 2013, Pages 305-316

  Kasprzak, Aldona ^a   Szaflarski, Witold ^a   Szmeja, Jacek ^a   Andrzejewska, Małgorzata ^a   Przybyszewska, Wiesława ^a   Kaczmarek, Elzbieta ^a   Koczorowska, Maria ^b   Kościński, Tomasz ^a   Zabel, MacIej ^a   Drews, Michał ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Colorectal carcinoma; Immunocytochemistry; Insulin like growth factor isoforms; Quantitative real time PCR

Indexed keywords

KI 67 ANTIGEN; RNA ISOFORM; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING;

ADENOCARCINOMA; ADULT; AGED; ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA ISOFORMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84873684196     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1706     Document Type: Article

References (51)

1. Donovan EA and Kummar S: Role of insulin-like growth factor-1R system in colorectal carcinogenesis. Crit Rev Oncol Hematol 66: 91-98, 2008. (Pubitemid 351446110)
2. Burroughs KD, Donn SE, Barrett JC and Taylor JA: Insulin-like growth factor-I: a key regulator of human cancer risk. J Natl Cancer Res 91: 579-581, 1999. (Pubitemid 29194043)
3. Ma J, Polak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH and Stampfer MJ: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625, 1999. (Pubitemid 29194048)
4. Giovanucci E: Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 51 (Suppl 3): 32-41, 1999.
5. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birbaum RS and Plymate SR: Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma to benign prostate epithelium. J Clin Endocrinol Metab 81: 3774-3782, 1996. (Pubitemid 26339953)
6. Baserga R: The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55: 249-255, 1995.
7. Cohen P: Overview of the IGF-I system. Horm Res 65 (Suppl 1): 3-8, 2006.
8. Wu Y, Yakar S, Zhao L, Henninghausen L and LeRoith D: Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62: 1030-1035, 2002. (Pubitemid 34160283)
9. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM and Egger M: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346-1353, 2004. (Pubitemid 38529873)
10. Rinaldi S, Cleveland R, Norat T, et al: Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126: 1702-1715, 2010.
11. Renehan AG, O'Dwyer ST and Ahalet SM: Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Res 91: 2051-2052, 1999.
12. Daughday WH and Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 10: 68-91, 1989. (Pubitemid 19156368)
13. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological functions. Endocr Rev 13: 3-34, 1995.
14. Murphy LJ: Insulin-like growth factor-binding proteins: functional diversity or redundancy? J Mol Endocrinol 21: 97-107, 1998. (Pubitemid 28557075)
15. Bell GI, Stempien MM, Fong NM and Rall LB: Sequences of liver cDNAs encoding two different mouse insulin-like growth factor 1 precursors. Nucleic Acids Res 14: 7873-7882, 1986.
16. Adamo ML: Regulation of insulin-like growth factor I gene expression. Implications for normal and pathological growth. Diabetes Rev 3: 2-27, 1995.
17. Temmerman L, Slonimsky E and Rosenthal N: Class 2 IGF-1 isoforms are dispensabile for viability, growth and maintenance of IGF-1 serum levels. Growth Horm IGF Res 20: 255-263, 2010.
18. Matheny RW Jr, Nindl BC and Adamo ML: Minireview: Mechano-Growth Factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151: 865-875, 2010.
19. Adamo ML, Ben-Hur H, LeRoith D and Roberts CT Jr: Transcription initiation in the two leader exons of the rat IGF-1 gene occurs from disperse versus localized sites. Biochem Biophys Res Commun 176: 887-893, 1991.
20. Simmons JG, Van Wyk JJ, Hoyt EC and Lund PK: Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitro. Growth Factors 9: 205-221, 1993. (Pubitemid 23310709)
21. Jansen M, van Schaik FM, Ricker AT, et al: Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 306: 609-611, 1983. (Pubitemid 14203833)
22. Rotwein P: Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc Natl Acad Sci USA 83: 77-81, 1986. (Pubitemid 16141618)
23. Shavlakadze T, Winn N, Rosenthal N and Grounds MD: Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm IGF Res 15: 4-18, 2005. (Pubitemid 40220850)
24. Chew SL, Lavender P, Clark AJ and Ross RJ: An alternatively spliced human insulin-like growth factor-1 transcript with hepatic tissue expression that diverts away from mitogenic IBE1 peptide. Endocrinology 136: 1939-1944, 1995.
25. Rotwein P, Pollock KM, Didier DK and Krivi GG: Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 261: 4828-4832, 1986. (Pubitemid 17204268)
26. Tian XC, Chen MJ, Pantschenko AG, Yang TJ and Chen TT: Recombinant E-peptides of pro-IGF-I have mitogenic activity. Endocrinology 140: 3387-3390, 1999. (Pubitemid 30650659)
27. Chen MJ, Chiou PP, Lin P, Lin CM, Siri S, Peck K and Chen TT: Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorionallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I. J Cell Biochem 101: 1316-1327, 2007. (Pubitemid 47253729)
28. Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA and Cuttitta F: A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci USA 89: 8107-8111, 1992.
29. McKoy G, Ashley W, Mander J, Yang SY, Williams N, Russell B and Goldspink G: Expression of insulin-like growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 516: 583-592, 1999. (Pubitemid 29204460)
30. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD and Goldspink G: The effect of recombinant human growth hormone and resistance training of IGF-I mRNA expression in the muscles of elderly men. J Physiol 555: 231-240, 2004. (Pubitemid 38313073)
31. Vinciquerra M, Santini MP, Claycomb WC, Ladurner AG and Rosenthal N: Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via Sirt1 activity. Aging (Albany NY) 2: 43-62, 2009.
32. Adamo ML, Neuenschwander S, LeRoith D and Roberts CT Jr: Structure, expression, and regulation of the IGF-I gene. Adv Exp Med Biol 343: 1-11, 1993. (Pubitemid 24059271)
33. Zarilli R, Bruni CB and Riccio A: Multiple levels of control of insulin-like growth factor gene expression. Mol Cell Endocrinol 101: R1-R14, 1994. (Pubitemid 24132765)
34. Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G and Groyer A: An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocellular cells against drug-induced apoptosis. Biochem Pharmacol 86: 1003-1015, 2004. (Pubitemid 39094263)
35. Samani AA, Yakar S, LeRoith D and Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47, 2007. (Pubitemid 46220849)
36. Garrouste F, Remacle-Bonnet M, Fauriat C, Marvaldi J, Luis J and Pommier G: Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. Cell Death Differ 9: 768-779, 2002. (Pubitemid 34778044)
37. Akagi Y, Liu W, Zebrowski B, Xie K and Ellis LM: Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res 58: 4008-4014, 1998. (Pubitemid 28405661)
38. Andre F, Rigot V, Thimonier J, et al: Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer 83: 497-505, 1999. (Pubitemid 29489865)
39. Armakolas A, Philippou A, Panteleakou Z, Nezos A, Sourla A, Petraki C and Koutsilieris M: Preferential expression of IGF-IEc (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells. Prostate 70: 1233-1242, 2010.
40. Koczorowska MM, Kwasniewska A and Gozdzicka-Jozefiak A: IGF1 mRNA isoform expression in the cervix of HPV-positive woman with pre-cancerous and cancer lesions. Exp Ther Med 2: 149-156, 2011.
41. Kasprzak A, Szaflarski W, Szmeja J, et al: Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer. Wspol Onkol 16: 147-153, 2012.
42. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981. (Pubitemid 11147380)
43. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987 (In German).
44. Gatter KC, Dunnill MS, Gerdes J, Stein H and Mason DY: New approach to assessing lung tumors in man. J Clin Pathol 39: 590-593, 1986. (Pubitemid 16069661)
45. Jehle PM, Fussgaenger RD, Blum WF, Angelus NK, Hoeflich A, Wolf E and Jungwirth RJ: Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components. Horm Metab Res 31: 97-102, 1999. (Pubitemid 29169482)
46. Freier S, Weiss O, Eran M, et al: Expression of the insulin-growth factors and their receptors in adenocarcinoma of the colon. Gut 44: 704-708, 1999. (Pubitemid 29195920)
47. Jenkins PJ, Khalaf S, Ogunkolade W, et al: Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Endocr Relat Cancer 12: 891-901, 2005. (Pubitemid 41815783)
48. Bustin SA, Dorudi S, Phillips SM, Feakins RM and Jenkins PJ: Local expression of insulin-like growth factor-I affects angiogenesis in colorectal cancer. Tumor Biol 23: 130-138, 2002. (Pubitemid 44858304)
49. Nosho K, Yamamoto H, Taniguchi H, et al: Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Clin Cancer Res 10: 7950-7957, 2004. (Pubitemid 39587535)
50. Michell NP, Langman MJS and Eggo MC: Insulin-like growth factors and their binding protein in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br J Cancer 76: 60-66, 1997. (Pubitemid 27250077)
51. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI and Shows TB: Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 46: 6169-6173, 1986. (Pubitemid 17221751)